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Summary Both coronary perforation and aneurysms associated with sirolimus-
eluting stent (SES) implantations are uncommon complications. We describe an
unusual case of a coronary aneurysm associated with a coronary perforation after
SES implantation. Although their pathogenesis has not yet been completely eluci-
dated, some technical factors including the use of excessive pressure during the
stent deployment, and sirolimus-induced vascular inﬂammatory reactions and poor
healing response at the perforation site may be related to the shape of the aneuris-
mal formation. Fortunately and interestingly, the size of the coronary aneurysm
gradually decreased, and ﬁnally by 26 months a nearly complete resolution of the
aneurysm had taken place. Furthermore, close follow-up by coronary 3-dimensional
computed tomography (3DCT) could clearly demonstrate the natural course of this
aneurysm. To the best of our knowledge, there have been no reports on the natu-
ral course of coronary aneurysm associated with a coronary perforation after SES(s)
implantation for more than 2 years using coronary 3DCT as in this present case.
The phenomenon of the spontaneous resolution of the coronary aneurysm after SES
implantation may have clinical therapeutic implications.
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ntroductionrug-eluting stents (DESs) have gained widespread
se due to the extraordinarily low rates of resten-
osis [1,2]. Despite the generally superior clinical
utcomes, some adverse events, including acute
gy. Published by Elsevier Ireland Ltd. All rights reserved.
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and late thrombosis [3], late incomplete apposi-
tion [4], and coronary aneurysms [5] at the DES
implantation site, have been reported. We describe
an unusual case of a coronary aneurysm associated
with a coronary perforation after DESs implanta-
tion, which could be closely followed-up for more
than 2 years using coronary 3-dimensional com-
puted tomography (3DCT).
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Figure 1 (ContinuedK.-i. Eshima et al.
ase report
77-year-old female was admitted to our hospi-
al with increasing episodes of chest pain on effort
nd fainting. Her coronary risk factors included a
amily history of ischemic heart disease, arterial
ypertension, and dyslipidemia. Both the electro-
ardiogram and echocardiogram on admission were
on next page).
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Figure 1 Left coronary angiography in the right anterior
oblique view obtained, before the percutaneous coronary
intervention (PCI) (A), during the balloon inﬂation at high
pressure at the overlapping stent region (E), rupture of
the overlapping stent region in the proximal left ante-
rior descending coronary artery (white arrows in F), after
adequate sealing of the coronary perforation (G), and 8
months after the PCI (H). The intravascular ultrasound
images reveal a plaque extension with mild calciﬁcation
(B—D). The black arrow in panel H indicates the coro-
nary aneurysm at the overlapping stent region. The white
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ued on anti-platelet therapy with 100mg per day ofFigure 1 (Continued ).
ormal. Since coronary angiography (CAG) revealed
hat there was one-vessel disease with a long, dif-
use narrow, and severe stenosis of the proximal left
nterior descending (LAD) coronary artery (Fig. 1A),
ercutaneous coronary intervention (PCI) with DESs
as performed.
A 6-Fr JL 3.5 Heartrail IITM guiding catheter
Terumo, Tokyo, Japan) was positioned in the
a
s
rrrows in panel G indicate the coronary expansion after
he stent deployment.
stium of the left main trunk (LMT). A Runthrough
STM guidewire (Terumo) was advanced into the
AD. After inﬂating a 2mm× 20mm Maverick IITM
alloon catheter (Boston Scientiﬁc Corporation,
atick, MA, USA) at the stenosis of the LAD, a
laque extension with mild calciﬁcation was con-
rmed with an Eagle EyeTM Gold intravascular
ltrasound catheter (IVUS) (Volcano Corporation,
an Diego, CA, USA) (Fig. 1B—D). Then, the
roximal LAD lesion was treated with two overlap-
ing 2.5mm× 28mm sirolimus-eluting stents (SESs)
Cordis Corporation, Miami Lakes, FL, USA) distally,
nd a 3.0mm× 18mm SES proximally (Fig. 1E).
ince the IVUS revealed incomplete stent dilation
t the overlapping stent region, a 3.0mm× 18mm
tent-mounted balloon was inﬂated at a high pres-
ure of 14 atm.
The next CAG revealed that a perforation had
ccurred at the overlapping region of the stents in
he proximal LAD (Fig. 1F). A 3mm× 20mm per-
usion balloon (EspritTM, Guidant, Santa Clara, CA,
SA) was immediately delivered to the rupture site,
nd inﬂated to 8 atm for 90min. A ﬁnal CAG showed
hat the perforation site was adequately sealed,
ut it appeared that a coronary expansion (white
rrow in Fig. 1G), probably resulting from selection
f oversize stents and excessive pressure during the
tent deployment, occurred and that the diagonal
ranch was occluded (Fig. 1G). An IVUS evaluation
f the rupture site could not be performed, because
he IVUS probe could not pass to that point. The
chocardiography revealed a mild pericardial effu-
ion without any cardiac tamponade and preserved
eft ventricular systolic function. The next day, the
erum creatine kinase (CK) level was not elevated.
efore her discharge, a permanent pacemaker was
mplanted for her sick sinus syndrome. She contin-spirin and 200mg per day of ticlopidine.
Eight months after the implantation of the SESs,
he was re-admitted to our hospital to evaluate the
uptured site. Although she was free from symp-
118 K.-i. Eshima et al.
Figure 2 A three-dimensional surface reconstruction shown from the right anterior oblique view (A—D), enlargement
tery
btain
limuimages of proximal left anterior descending coronary ar
level of the proximal LAD with coronary aneurysm (I—L) o
26 months (D, H, and L) after the implantation of the siro
aneurysm in the proximal LAD.toms and the CAG (Fig. 1H) and coronary 3DCT
(Fig. 2A, E and I) revealed no restenosis at the
SES implantation sites, a coronary aneurysm with
a diameter of 2.8mm× 3.7mm was conﬁrmed at
t
l
f
t(LAD) (E—H), and trans-axis cross-sectional view at the
ed 8 (A, E, and I), 12 (B, F, and J), 18 (C, G, and K), and
s-eluting stents. The white arrows indicate the coronaryhe coronary perforation site where the SESs over-
apped. Since the trans-axis cross-sectional view
rom coronary 3DCT revealed unclear existence of
he vascular wall around the coronary aneurysm, we
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woronary aneurysm after DES implantation
uspected pseudo-type coronary aneurysm. Thus,
he discontinued anti-platelet therapy with ticlo-
idine, but continued aspirin. Then, we continued
ith careful medical management, and the coro-
ary 3DCTs were re-performed at 12 (Fig. 2B, F,
nd J), 18 (Fig. 2C, G, and K), and 26 months
Fig. 2D, H, and L) after the implantation of the
ESs. Fortunately and interestingly, although the
oronary expansion remained, the size of the coro-
ary aneurysm gradually decreased, and ﬁnally by
6 months a nearly complete resolution of the
neurysm had taken place. She has remained well
ithout any symptoms for more than 2 years after
he implantation of the SESs.
iscussion
oronary perforation associated with PCI is a seri-
us, but rare, complication, and its frequency is
nly 0.5% [6]. It has been similarly reported that
oronary aneurysms are uncommon complications
fter DES implantations [5,7], and their incidence
n the RAVEL study [4] and TAXUS V trial [8] was
nly 0.4% or 1.4% after SES(s) or paclitaxel-eluting
tent(s) implantations, respectively, as compared
ith a 0.2% prevalence for bare metal stent(s). We
escribe an unusual case of a coronary aneurysm
ssociated with a coronary perforation after DES
mplantation.
Although the pathogenesis of coronary
neurysms has not yet been completely eluci-
ated, some possible mechanisms have been
aised. As two recent case reports described [5,9],
ome technical factors including the use of exces-
ive pressure during the stent deployment leading
o injury of the media of the coronary arteries may
e related to the shape of the aneurismal forma-
ion. On the other hand, pathologic examination
f aneurysms after DES implantations has revealed
rug or polymer-induced localized vascular inﬂam-
atory reactions and/or impaired vessel healing
10], which have not been observed after BMS
mplantations. In this present case, the ﬁnal CAG
Fig. 1G) and coronary 3DCT (Fig. 2A—D) showed a
oronary expansion at the perforation site probably
ue to selection of oversize stents and excessive
ressure during the stent deployment leading
o the disruption of the media of the coronary
rteries. In view of these ﬁndings, the elevated
oncentration of sirolimus at the overlapping SES
egion may have induced and/or accelerated a
trong vascular inﬂammation reaction and poor
ealing response [10] at the coronary perforation
nd/or disruption site, and ﬁnally developed into
n aneurysm formation.
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The coronary aneurysms occurring after the
mplantation of DESs may be unusual complications.
ince they may cause serious problems including
neurysm dilation developing to ruptures or throm-
oses [11] which may be accelerated by sirolimus,
hysicians should be aware of the condition, and a
urgical excision, percutaneous coiling, or covering
y stent implantations may be considered accord-
ng to the circumstances [5]. In this present case,
owever, fortunately and interestingly, the size of
he coronary aneurysm gradually decreased, and
nally by 26 months a nearly complete resolution of
he aneurysm had taken place. Furthermore, close
ollow-up by coronary 3DCT could clearly demon-
trate the natural course of the aneurysm. Thus, the
oronary 3DCT may be one of the most non-invasive
nd convenient diagnostic strategies for following
p coronary aneurysms.
Although the mechanisms of the resolution of
he aneurysm are still not understood, we presume
hat a thrombus may gradually form and ﬁll up the
neurysm, and ﬁnally, the nearly complete resolu-
ion of the aneurysm may take place after more
han 2 years. Although, to conﬁrm our hypothesis,
e tried to evaluate the properties of the aneurysm
y using the Hounsﬁeld unit in the coronary 3DCT
12], we could not measure it, because the halation
rom the stents affected the Hounsﬁeld unit val-
es in the aneurysm. However, an in vitro study has
hown that the expression of tissue factor, which
lays an important role in thrombus formation,
s strongly enhanced by sirolimus in human aortic
ndothelial cells [13], supporting our hypothesis.
To the best of our knowledge, there have been
o reports on the clear demonstration of the nat-
ral course of coronary aneurysm associated with
coronary perforation after DES(s) implantation
y using coronary 3DCT for more than 2 years as
n this present case. Although the natural history
nd adequate treatment of coronary aneurysms is
urrently still unknown, physicians should follow
p them closely. The phenomenon of the sponta-
eous resolution of the coronary aneurysm after
ES implantation may have clinical therapeutic
mplications.
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